« Return to News | Study Conduct

UK firms go to Russia to conduct cheaper clinical trials

Tuesday, September 20, 2011 11:13 AM

Britain's fastest-growing bio-technology firms are flocking to Russia to run clinical trials more cheaply and quickly than they can in the West, according to This is MONEY.

The Kremlin is providing generous backing for Rusnano, a nanotechnology venture fund. It is also luring biotech firms in a bid to establish Russia as a leading center for pharmaceutical research and development.

It takes “half the time and one tenth of the cost” to run clinical trials in Russia, according to the boss of Xenetic Biosciences. The London-based firm is developing 12 drugs in Russia with Anglo-Russian collaboration and Rusnano funding.

Scott Maguire, chief executive of Xenetic, said, “Regulators do not take as much time to make a decision in Russia and the data you need to go into a trial is not as extensive as in Britain and the US.”

“More biotechs will consider taking this route. Where else are companies going to get the tens of millions of pounds required to run clinical trials?” said Maguire.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.